India Pharma Outlook Team | Tuesday, 13 October 2026
Karnataka empowers patients with transparent medicine pricing details that will appear on every hospital bill from November 1.
The state Food Safety and Drugs Administration now requires hospitals to list the actual procurement cost, the printed MRP, and the final amount charged for every medicine, medical device, and consumable.
Patients and their families will finally see the true gap between what hospitals pay and what they bill.
This shift puts clear numbers in patients’ hands and gives them a practical tool to question high mark-ups on everyday items such as IV sets and costly cancer injectables. The order covers all government, private and trust hospitals across the state.
Hospitals must issue fully itemized bills. Each line will carry the product name (generic and brand), batch number, manufacturing date, expiry date, landing or base price (actual cost to the hospital exclusive of taxes), MRP, price charged to the patient, and any extra taxes.
The charged price cannot exceed the MRP. Hospitals must also place notices at billing counters, pharmacy counters and admission desks and publish the policy on their websites. They must keep purchase and billing records for three years.
Key details patients will now see:
Also Read: India's Drug Pricing Architecture: Why the Rules Keep Expanding
Earlier, a patient often received only a single high figure. Now the same items will reveal the mark-up in plain sight.
These side-by-side numbers let an attendant immediately notice when a hospital adds several times the actual cost.
Patients and attendants can now act with confidence.
The state has already identified large gaps on 253 medicines and consumables and has written to the center seeking tighter controls on cancer drugs.
The Association of Indian Medical Device Industry welcomes the move but points out that hospital-level disclosure captures only the final margin. Rajiv Nath of AiMeD urges mapping of every stage from the manufacturer’s selling price or import landed cost, through distributors and wholesalers, all the way to the patient.
Recording the transaction value at each invoice would show regulators exactly where prices rise. AiMeD has asked the Department of Pharmaceuticals to hold consultations and run pilot projects before wider trade-margin rules take effect.
Karnataka’s order already creates the foundation; fuller chain-wide data would make future policy sharper and fairer.
This single reform turns opaque hospital bills into readable documents. Patients gain the numbers they need, hospitals face clearer accountability, and the state sets a practical model that other regions can study.